drugset / Trial / NCT00099515

Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)

NCT00099515

Phase 2 Completed 97 enrolled Eli Lilly and Company Alkermes, Inc. · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare intensive and standard training for human insulin inhalation powder in patients with type 2 diabetes.

Timeline

Start
2004-11
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Background Insulin Protein / enzyme biologic 6 iu Inhaled
Background Insulin Protein / enzyme biologic 60 iu Inhaled